Calpain and STriatal-Enriched protein tyrosine Phosphatase (STEP) activation contribute to extrasynaptic NMDA receptor localization in a huntington's disease mouse model

Human Molecular Genetics

Volumn 21, Issue 17, 2012, Pages 3739-3752

  Gladding, Clare M ^a   Sepers, Marja D ^a   Xu, Jian ^b   Zhang, Lily Y J ^a   Milnerwood, Austen J ^a   Lombroso, Paul J ^b   Raymond, Lynn A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALPAIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN TYROSINE PHOSPHATASE; STRIATAL ENRICHED PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INACTIVATION; FEMALE; HUNTINGTON CHOREA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ANIMALS; CALPAIN; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; ENZYME INHIBITORS; HUNTINGTON DISEASE; ION CHANNEL GATING; MICE; MODELS, BIOLOGICAL; NEOSTRIATUM; NEURONS; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN TRANSPORT; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPSES;

EID: 84865078592     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds154     Document Type: Article

References (70)

1. Bliss, T.V. and Collingridge, G.L. (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature, 361, 31-39.
2. Arundine, M. and Tymianski, M. (2003) Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium, 34, 325-337.
3. Gladding, C.M. and Raymond, L.A. (2011) Mechanisms underlying NMDA receptor synaptic/extrasynaptic distribution and function. Mol. Cell Neurosci, 48, 308-320.
4. Lau, C.G. and Zukin, R.S. (2007) NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat. Rev. Neurosci., 8, 413-426.
5. Graveland, G.A., Williams, R.S. and DiFiglia, M. (1985) Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science, 227, 770-773.
6. HDCRG (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell, 72, 971-983.
7. Cepeda, C., Ariano, M.A., Calvert, C.R., Flores-Hernandez, J., Chandler, S.H., Leavitt, B.R., Hayden, M.R. and Levine, M.S. (2001) NMDA receptor function in mouse models of Huntington disease. J. Neurosci. Res., 66, 525-539.
8. Fan, M.M., Fernandes, H.B., Zhang, L.Y., Hayden, M.R. and Raymond, L.A. (2007) Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease. J. Neurosci., 27, 3768-3779.
9. Graham, R.K., Pouladi, M.A., Joshi, P., Lu, G., Deng, Y., Wu, N.P., Figueroa, B.E., Metzler, M., Andre, V.M., Slow, E.J. et al. (2009) Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease. J. Neurosci., 29, 2193-2204.
10. Li, L., Murphy, T.H., Hayden, M.R. and Raymond, L.A. (2004) Enhanced striatal NR2B-containing N-methyl-D-aspartate receptor-mediated synaptic currents in a mouse model of Huntington disease. J. Neurophysiol., 92, 2738-2746.
11. Milnerwood, A.J. and Raymond, L.A. (2007) Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load. J. Physiol., 585, 817-831.
12. Shehadeh, J., Fernandes, H.B., Zeron Mullins, M.M., Graham, R.K., Leavitt, B.R., Hayden, M.R. and Raymond, L.A. (2006) Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease. Neurobiol. Dis., 21, 392-403.
13. Tang, T.S., Slow, E., Lupu, V., Stavrovskaya, I.G., Sugimori, M., Llinas, R., Kristal, B.S., Hayden, M.R. and Bezprozvanny, I. (2005) Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. Proc. Natl. Acad. Sci. USA, 102, 2602-2607.
14. Zeron, M.M., Hansson, O., Chen, N., Wellington, C.L., Leavitt, B.R., Brundin, P., Hayden, M.R. and Raymond, L.A. (2002) Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron, 33, 849-860.
15. Chen, N., Luo, T., Wellington, C., Metzler, M., McCutcheon, K., Hayden, M.R. and Raymond, L.A. (1999) Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin. J. Neurochem., 72, 1890-1898.
16. Fan, J., Cowan, C.M., Zhang, L.Y., Hayden, M.R. and Raymond, L.A. (2009) Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington's disease. J. Neurosci., 29, 10928-10938.
17. Milnerwood, A.J., Gladding, C.M., Pouladi, M.A., Kaufman, A.M., Hines, R.M., Boyd, J.D., Ko, R.W., Vasuta, O.C., Graham, R.K., Hayden, M.R. et al. (2010) Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice. Neuron, 65, 178-190.
18. Song, C., Zhang, Y., Parsons, C.G. and Liu, Y.F. (2003) Expression of polyglutamine-expanded huntingtin induces tyrosine phosphorylation of N-methyl-D-aspartate receptors. J. Biol. Chem., 278, 33364-33369.
19. Hardingham, G.E., Fukunaga, Y. and Bading, H. (2002) Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat. Neurosci., 5, 405-414.
20. Leveille, F., El Gaamouch, F., Gouix, E., Lecocq, M., Lobner, D., Nicole, O. and Buisson, A. (2008) Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors. Faseb J., 22, 4258-4271.
21. Okamoto, S., Pouladi, M.A., Talantova, M., Yao, D., Xia, P., Ehrnhoefer, D.E., Zaidi, R., Clemente, A., Kaul, M., Graham, R.K. et al. (2009) Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin. Nat. Med., 15, 1407-1413.
22. Groc, L., Bard, L. and Choquet, D. (2009) Surface trafficking of N-methyl-D-aspartate receptors: physiological and pathological perspectives. Neuroscience, 158, 4-18.
23. Hardingham, G.E. and Bading, H. (2010) Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat. Rev. Neurosci., 11, 682-696.
24. Petralia, R.S., Al-Hallaq, R.A. and Wenthold, R.J. (2009) Trafficking and Targeting of NMDA Receptors. In Van Dongen, A.M. (ed.), Biology of the NMDA Receptor. CRC Press, Chapter 8.
25. Guttmann, R.P., Baker, D.L., Seifert, K.M., Cohen, A.S., Coulter, D.A. and Lynch, D.R. (2001) Specific proteolysis of the NR2 subunit at multiple sites by calpain. J. Neurochem., 78, 1083-1093.
26. Guttmann, R.P., Sokol, S., Baker, D.L., Simpkins, K.L., Dong, Y. and Lynch, D.R. (2002) Proteolysis of the N-methyl-d-aspartate receptor by calpain in situ. J. Pharmacol. Exp. Ther., 302, 1023-1030.
27. Cowan, C.M., Fan, M.M., Fan, J., Shehadeh, J., Zhang, L.Y., Graham, R.K., Hayden, M.R. and Raymond, L.A. (2008) Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity. J. Neurosci., 28, 12725-12735.
28. Gafni, J. and Ellerby, L.M. (2002) Calpain activation in Huntington's disease. J. Neurosci., 22, 4842-4849.
29. Braithwaite, S.P., Adkisson, M., Leung, J., Nava, A., Masterson, B., Urfer, R., Oksenberg, D. and Nikolich, K. (2006) Regulation of NMDA receptor trafficking and function by striatal-enriched tyrosine phosphatase (STEP). Eur. J. Neurosci., 23, 2847-2856.
30. Pelkey, K.A., Askalan, R., Paul, S., Kalia, L.V., Nguyen, T.H., Pitcher, G.M., Salter, M.W. and Lombroso, P.J. (2002) Tyrosine phosphatase STEP is a tonic brake on induction of long-term potentiation. Neuron, 34, 127-138.
31. Snyder, E.M., Nong, Y., Almeida, C.G., Paul, S., Moran, T., Choi, E.Y., Nairn, A.C., Salter, M.W., Lombroso, P.J., Gouras, G.K. et al. (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci., 8, 1051-1058.
32. Saavedra, A., Giralt, A., Rue, L., Xifro, X., Xu, J., Ortega, Z., Lucas, J.J., Lombroso, P.J., Alberch, J. and Perez-Navarro, E. (2011) Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington's disease: a STEP in the resistance to excitotoxicity. J. Neurosci., 31, 8150-8162.
33. Paul, S., Nairn, A.C., Wang, P. and Lombroso, P.J. (2003) NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling. Nat. Neurosci., 6, 34-42.
34. Xifro, X., Garcia-Martinez, J.M., Del Toro, D., Alberch, J. and Perez-Navarro, E. (2008) Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells. J. Neurochem., 105, 1596-1612.
35. Prybylowski, K., Chang, K., Sans, N., Kan, L., Vicini, S. and Wenthold, R.J. (2005) The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2. Neuron, 47, 845-857.
36. Goebel-Goody, S.M., Davies, K.D., Alvestad Linger, R.M., Freund, R.K. and Browning, M.D. (2009) Phospho-regulation of synaptic and extrasynaptic N-methyl-d-aspartate receptors in adult hippocampal slices. Neuroscience, 158, 1446-1459.
37. Jiang, X., Knox, R., Pathipati, P. and Ferriero, D. (2011) Developmental localization of NMDA receptors, Src and MAP kinases in mouse brain. Neurosci. Lett., 503, 215-219.
38. Paul, S., Olausson, P., Venkitaramani, D.V., Ruchkina, I., Moran, T.D., Tronson, N., Mills, E., Hakim, S., Salter, M.W., Taylor, J.R. et al. (2007) The striatal-enriched protein tyrosine phosphatase gates long-termpotentiation and fear memory in the lateral amygdala. Biol. Psychiatry, 61, 1049-1061.
39. Zhang, Y., Venkitaramani, D.V., Gladding, C.M., Kurup, P., Molnar, E., Collingridge, G.L. and Lombroso, P.J. (2008) The tyrosine phosphatase STEP mediates AMPA receptor endocytosis after metabotropic glutamate receptor stimulation. J. Neurosci., 28, 10561-10566.
40. Fan, M.M. and Raymond, L.A. (2007) N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease. Prog. Neurobiol., 81, 272-293.
41. Milnerwood, A.J. and Raymond, L.A. (2010) Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease. Trends Neurosci., 33, 513-523.
42. Zhang, H., Li, Q., Graham, R.K., Slow, E., Hayden, M.R. and Bezprozvanny, I. (2008) Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease. Neurobiol. Dis., 31, 80-88.
43. Cowan, C.M. and Raymond, L.A. (2006) Selective neuronal degeneration in Huntington's disease. Curr. Top. Dev. Biol., 75, 25-71.
44. Bezprozvanny, I. and Hayden, M.R. (2004) Deranged neuronal calcium signaling and Huntington disease. Biochem. Biophys. Res. Commun., 322, 1310-1317.
45. Giacomello, M., Hudec, R. and Lopreiato, R. (2011) Huntington's disease, calcium, and mitochondria. Biofactors, 37, 206-218.
46. Oliveira, J.M. (2010) Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum. J. Neurochem., 114, 1-12.
47. Fernandes, H.B., Baimbridge, K.G., Church, J., Hayden, M.R. and Raymond, L.A. (2007) Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington's disease. J. Neurosci., 27, 13614-13623.
48. Gafni, J., Hermel, E., Young, J.E., Wellington, C.L., Hayden, M.R. and Ellerby, L.M. (2004) Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus. J. Biol. Chem., 279, 20211-20220.
49. Kim, Y.J., Yi, Y., Sapp, E., Wang, Y., Cuiffo, B., Kegel, K.B., Qin, Z.H., Aronin, N. and DiFiglia, M. (2001) Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc. Natl. Acad. Sci. USA, 98, 12784-12789.
50. Wu, H.Y., Hsu, F.C., Gleichman, A.J., Baconguis, I., Coulter, D.A. and Lynch, D.R. (2007) Fyn-mediated phosphorylation of NR2B Tyr-1336 controls calpain-mediated NR2B cleavage in neurons and heterologous systems. J. Biol. Chem., 282, 20075-20087.
51. Xu, J., Kurup, P., Zhang, Y., Goebel-Goody, S.M., Wu, P.H., Hawasli, A.H., Baum, M.L., Bibb, J.A. and Lombroso, P.J. (2009) Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP. J. Neurosci., 29, 9330-9343.
52. Simpkins, K.L., Guttmann, R.P., Dong, Y., Chen, Z., Sokol, S., Neumar, R.W. and Lynch, D.R. (2003) Selective activation induced cleavage of the NR2B subunit by calpain. J. Neurosci., 23, 11322-11331.
53. Yuen, E.Y., Ren, Y. and Yan, Z. (2008) Postsynaptic density-95 (PSD-95) and calcineurin control the sensitivity of N-methyl-D-aspartate receptors to calpain cleavage in cortical neurons. Mol. Pharmacol., 74, 360-370.
54. Scott, D.B., Michailidis, I., Mu, Y., Logothetis, D. and Ehlers, M.D. (2004) Endocytosis and degradative sorting of NMDA receptors by conserved membrane-proximal signals. J. Neurosci., 24, 7096-7109.
55. Rudinskiy, N., Grishchuk, Y., Vaslin, A., Puyal, J., Delacourte, A., Hirling, H., Clarke, P.G. and Luthi-Carter, R. (2009) Calpain hydrolysis of alpha- and beta2-adaptins decreases clathrin-dependent endocytosis and may promote neurodegeneration. J. Biol. Chem., 284, 12447-12458.
56. Paoletti, P., Vila, I., Rife, M., Lizcano, J.M., Alberch, J. and Gines, S. (2008) Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25/cyclin-dependent kinase 5. J. Neurosci., 28, 10090-10101.
57. Spektor, B.S., Miller, D.W., Hollingsworth, Z.R., Kaneko, Y.A., Solano, S.M., Johnson, J.M., Penney, J.B. Jr, Young, A.B. and Luthi-Carter, R. (2002) Differential D1 and D2 receptor-mediated effects on immediate early gene induction in a transgenic mouse model of Huntington's disease. Brain Res. Mol. Brain Res., 102, 118-128.
58. Tang, T.S., Chen, X., Liu, J. and Bezprozvanny, I. (2007) Dopaminergic signaling and striatal neurodegeneration in Huntington's disease. J. Neurosci., 27, 7899-7910.
59. Pardo, R., Colin, E., Regulier, E., Aebischer, P., Deglon, N., Humbert, S. and Saudou, F. (2006) Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421. J. Neurosci., 26, 1635-1645.
60. Rosenstock, T.R., de Brito, O.M., Lombardi, V., Louros, S., Ribeiro, M., Almeida, S., Ferreira, I.L., Oliveira, C.R. and Rego, A.C. (2011) FK506 ameliorates cell death features in Huntington's disease striatal cell models. Neurochem. Int., 59, 600-609.
61. Groc, L. and Choquet, D. (2006) AMPA and NMDA glutamate receptor trafficking: multiple roads for reaching and leaving the synapse. Cell Tissue Res., 326, 423-438.
62. Groc, L., Heine, M., Cognet, L., Brickley, K., Stephenson, F.A., Lounis, B. and Choquet, D. (2004) Differential activity-dependent regulation of the lateral mobilities of AMPA and NMDA receptors. Nat. Neurosci., 7, 695-696.
63. Groc, L., Heine, M., Cousins, S.L., Stephenson, F.A., Lounis, B., Cognet, L. and Choquet, D. (2006) NMDA receptor surface mobility depends on NR2A-2B subunits. Proc. Natl. Acad. Sci. USA, 103, 18769-18774.
64. Kaech, S. and Banker, G. (2006) Culturing hippocampal neurons. Nat. Protoc., 1, 2406-2415.
65. Niwa, H., Yamamura, K. and Miyazaki, J. (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene, 108, 193-199.
66. Kim, M.J., Dunah, A.W., Wang, Y.T. and Sheng, M. (2005) Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. Neuron, 46, 745-760.
67. Pacchioni, A.M., Vallone, J., Worley, P.F. and Kalivas, P.W. (2009) Neuronal pentraxins modulate cocaine-induced neuroadaptations. J. Pharmacol. Exp. Ther., 328, 183-192.
68. Boulanger, L.M., Lombroso, P.J., Raghunathan, A., During, M.J., Wahle, P. and Naegele, J.R. (1995) Cellular and molecular characterization of a brain-enriched protein tyrosine phosphatase. J. Neurosci., 15, 1532-1544.
69. Suh, Y.H., Terashima, A., Petralia, R.S., Wenthold, R.J., Isaac, J.T., Roche, K.W. and Roche, P.A. (2010) A neuronal role for SNAP-23 in postsynaptic glutamate receptor trafficking. Nat. Neurosci., 13, 338-343.
70. Tapia, L., Milnerwood, A., Guo, A., Mills, F., Yoshida, E., Vasuta, C., Mackenzie, I.R., Raymond, L., Cynader, M., Jia, W. et al. (2011) Progranulin deficiency decreases gross neural connectivity but enhances transmission at individual synapses. J. Neurosci., 31, 11126-11132.